Literature DB >> 1764385

Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951.

G Lundegårdh1, A Lindgren, A Rohul, O Nyrén, L E Hansson, R Bergström, H O Adami.   

Abstract

In order to test the hypothesis that the general decline in gastric cancer observed in many countries is due to a selective decline in Laurén's intestinal type, we re-examined all 427 histologic sections obtained from gastric carcinomas diagnosed at the Department of Pathology, University Hospital, Uppsala, Sweden, in 1951, 1961, 1971-72 and 1981. The relative proportions of intestinal and diffuse type cancers were compared. The intestinal type was significantly (P less than 0.001) more common among elderly people than in the younger age groups. The relative proportions of intestinal type carcinoma in the four periods under study were 65%, 55%, 42% and 60%, respectively. The absence of any clearly discernible trend over time contradicts the hypothesis of diverse secular trends for intestinal and diffuse types of gastric carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 1764385      PMCID: PMC1977875          DOI: 10.1038/bjc.1991.487

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants.

Authors:  P Correa; C Cuello; E Duque
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Time trends of intestinal and diffuse types of gastric cancer in the United States.

Authors:  N Muñoz; R Connelly
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

5.  Geographical pathology of gastric carcinoma: a comparative study on histological types between high and low mortality areas in Japan.

Authors:  T Kubo; H Tsunoda; S Tanaka; J Soga
Journal:  Gan       Date:  1981-04

6.  Changes in the histologic types of gastric carcinoma in Japan.

Authors:  Y Kato; T Kitagawa; K Nakamura; H Sugano
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

7.  Clinical implications of recent developments in gastric cancer pathology and epidemiology.

Authors:  P Correa
Journal:  Semin Oncol       Date:  1985-03       Impact factor: 4.929

8.  Intestinal and diffuse carcinoma of the stomach among the ethnic and dialect groups in Singapore.

Authors:  M Teh; Y S Lee
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

9.  Changes in the location and type of gastric adenocarcinoma.

Authors:  D A Antonioli; H Goldman
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

10.  On the reputed decline in gastric carcinoma: necropsy study from western Norway.

Authors:  H Maartmann-Moe; F Hartveit
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12
View more
  4 in total

Review 1.  Clinical epidemiology of gastric cancer.

Authors:  Tiing Leong Ang; Kwong Ming Fock
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

2.  General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors.

Authors:  Ozlem Canöz; Olcay Belenli; Tahír E Patiroglu
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

3.  Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.

Authors:  Jennifer M Yeh; Karen M Kuntz; Majid Ezzati; Sue J Goldie
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

4.  Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden.

Authors:  A M Ekström; L E Hansson; L B Signorello; A Lindgren; R Bergström; O Nyrén
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.